About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
D
Treatment Updates and Management of Non-Hodgkin Lymphomas
By
Integrity CE
FEATURING
Danielle Wallace
,
Matthew Cortese
By
Integrity CE
FEATURING
Danielle Wallace
,
Matthew Cortese
74 views
August 7, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Related Content
AUTOPLAY
ON
Moffitt Cancer Center
2024 Cell Coast Conference
Fri, Oct 25, 2024
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
Feat.
B. D. Cheson
22:11
SOHO Brazil 2024
Has the 1L SoC Truly Changed in Advanced Stage DLBCL?
Feat.
A. Zelenetz
13:07
Moffitt Cancer Center
R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?
Feat.
J. Chavez
27:47
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…
Feat.
S. Smith
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
08:18
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
Feat.
A. Zhou
06:33
Christopher Flowers
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
35:27
Louisville Hematology Highlights
Updates on Management of DLBCL
Feat.
J. Leonard
19:14
SOHO Brazil 2024
FL: How Do I Deal With Relapse?
Feat.
B. Kahl
10:04
Tara Graff
How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…
09:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…
Feat.
J. Westin
20:18
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Will Immune Therapy Replace Transplant in Hematologic Malignancies?
Feat.
R. Gale
13:56
SOHO 2023 Eleventh Annual Meeting
Follicular Lymphoma Management: What Is the New Order?
Feat.
B. Kahl
20:34
UChicago Medicine
Sequencing of Bispecifics With Other Therapies in DLBCL
Feat.
E. Budde
27:51
Louisville Hematology Highlights
Summary of Recent Advances in Follicular Lymphoma
Feat.
S. Gaballa
25:47
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in Indolent B-Cell Lymphomas
Feat.
J. Soumerai
04:32
Yasmin Karimi
FDA Approval of Epcoritamab in R/R FL: What You Need to Know
08:23
Total Health
R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment
Feat.
J. Chandler,
B. Randolph,
M. Onciu
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
